New Results
Abnormal CCK/CB1R axon targeting in mouse models of dystroglycanopathy
View ORCID ProfileDaniel S. Miller, View ORCID ProfileJennifer N. Jahncke, View ORCID ProfileEric Schnell, View ORCID ProfileKevin M. Wright
doi: https://doi.org/10.1101/2022.01.26.477791
Daniel S. Miller
1Neuroscience Graduate Program, Oregon Health & Science University, Portland, OR 97239, USA
Jennifer N. Jahncke
1Neuroscience Graduate Program, Oregon Health & Science University, Portland, OR 97239, USA
Eric Schnell
2Operative Care Division, Portland VA Health Care System
3Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, OR 97239, USA
Kevin M. Wright
4Vollum Institute, Oregon Health & Science University, Portland, OR 97239, USA

Article usage
Posted January 26, 2022.
Abnormal CCK/CB1R axon targeting in mouse models of dystroglycanopathy
Daniel S. Miller, Jennifer N. Jahncke, Eric Schnell, Kevin M. Wright
bioRxiv 2022.01.26.477791; doi: https://doi.org/10.1101/2022.01.26.477791
Subject Area
Subject Areas
- Biochemistry (7585)
- Bioengineering (5533)
- Bioinformatics (20825)
- Biophysics (10344)
- Cancer Biology (7995)
- Cell Biology (11653)
- Clinical Trials (138)
- Developmental Biology (6617)
- Ecology (10224)
- Epidemiology (2065)
- Evolutionary Biology (13639)
- Genetics (9557)
- Genomics (12856)
- Immunology (7930)
- Microbiology (19568)
- Molecular Biology (7675)
- Neuroscience (42182)
- Paleontology (308)
- Pathology (1259)
- Pharmacology and Toxicology (2208)
- Physiology (3271)
- Plant Biology (7058)
- Synthetic Biology (1953)
- Systems Biology (5433)
- Zoology (1119)